Axos Financial

AX · NYSE

$89.86+$1.94 (+2.21%)TodayMarket closed · Oct 20, 7:30 PM ET

Prev close $87.92

AX analyst rating

BuyConsensus of 6 analysts over the last 12 months. 83% rate it a buy.

Strong buy1
Buy4
Hold1
Underperform0
Sell0

12-month price target · 10 analysts

Average $120.07 (+33.6% upside)

Low: $111.10
Now: $89.86
High: $134.40

Upgrades and downgrades

The latest rating actions, newest first

AX analyst upgrades, downgrades and rating actions
Firm	Date	Action	Rating	Price target	Hit rate
Needham	Oct 5, 2026	Maintains	Buy	$128.00	40%
Benchmark	Aug 13, 2026	Maintains	Buy	$115.00 → $120.00	70%
Needham	Jul 31, 2026	Maintains	Buy	$110.00 → $128.00	40%
Keefe, Bruyette & Woods	Jul 31, 2026	Maintains	Market Perform	$105.00 → $110.00	63%
Benchmark	Jul 9, 2026	Initiates	Buy	$115.00	70%
Raymond James	Apr 7, 2026	Upgrade	Outperform → Strong Buy	$110.00 → $100.00	66%
Needham	Mar 16, 2026	Maintains	Buy	$110.00	40%
Needham	Feb 13, 2026	Maintains	Buy	$110.00	40%
Jefferies	Jan 30, 2026	Maintains	Buy	$110.00 → $115.00	66%
DA Davidson	Jan 30, 2026	Maintains	Buy	$107.50 → $112.00	78%

The case for and against

Updated Oct 17, 2026

Bull case

Axos Financial is favored because its digitally driven, full-bank model supports superior unit economics, low- to mid-teens loan growth, and industry-leading profitability, with roughly 17% ROTCE, 1.75% ROA, and a net interest margin near 4.50%. Its acquisition of Arc Technologies should deepen the SMB and mid-market franchise by adding cash management, card issuance, rewards, and financing tools that can lift loan, deposit, and fee income over the medium term. The outlook is further strengthened by ~75% variable-rate loans, a diversified nationwide lending mix, strong underwriting with a 46% weighted-average LTV in specialty CRE, and robust capital generation, including 17% 10-year TBV/share CAGR and CET1 of 11.7%.

Bear case

Axos Financial is vulnerable to a slowdown in growth because its balance-sheet lending model depends heavily on continued loan expansion, and any credit deterioration in the customer base could force management to pull back while also pressuring profitability and regulatory capital ratios. The company also faces meaningful margin risk from rising funding costs, volatile rates, and competition on both the loan and deposit sides, which could compress net interest margin and weaken earnings growth. Although March 31 nonperforming assets were $180 million, or 0.72% of loans and OREO, the presence of $98 million of nonaccrual C&I loans and a $33 million shared national credit migrated in FY 3Q26 supports a cautious view given the added regulatory scrutiny of a full banking license.

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.